Introgen Files Advexin For Head And Neck Cancer In U.S., EU

Biotech says it hopes to follow the Idec/Rituxan model in bringing oncologic gene therapy to the U.S. market.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet